Glen Eagle Advisors, LLC Fulgent Genetics, Inc. Transaction History

Glen Eagle Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Aug 13, 2024	SELL	$77.3 - $105.0 $10,203 - $13,860	-132 Closed	0 $0
Q3 2021 Aug 13, 2024	BUY	$74.87 - $110.87 $2,021 - $2,993	27 Added 25.71%	132 $11.9 Million
Q1 2021 Aug 13, 2024	SELL	$59.3 - $183.85 $11,563 - $35,850	-195 Reduced 65.0%	105 $10.1 Million
Q4 2020 Aug 13, 2024	BUY	$31.01 - $52.1 $9,303 - $15,630	300 New	300 $15.6 Million
Q4 2019 Aug 13, 2024	BUY	$9.29 - $15.82 $1,857 - $3,164	200 Added 200.0%	300 $3.87 Million
Q3 2019 Aug 13, 2024	BUY	$5.96 - $12.81 $596 - $1,281	100 New	100 $1.04 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $612M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.